{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T20:10:11Z","timestamp":1785528611390,"version":"3.56.0"},"reference-count":95,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T00:00:00Z","timestamp":1752710400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.vaccine.2025.127486","type":"journal-article","created":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T23:40:35Z","timestamp":1752795635000},"page":"127486","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Culture filtrate proteins from Bacillus Calmette\u2013Gu\u00e9rin"],"prefix":"10.1016","volume":"62","author":[{"given":"Yukihiro","family":"Shibuya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"39","key":"10.1016\/j.vaccine.2025.127486_bb0005","doi-asserted-by":"crossref","first-page":"5035","DOI":"10.1016\/j.vaccine.2015.08.033","article-title":"Prospects in Mycobacterium bovis Bacille Calmette et Gu\u00e9rin (BCG) vaccine diversity and delivery: why does BCG fail to protect against tuberculosis?","volume":"33","author":"Moliva","year":"2015","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2025.127486_bb0010","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/j.vaccine.2021.01.068","article-title":"Can what have we learnt about BCG vaccination in the last 20 years help us to design a better tuberculosis vaccine?","volume":"40","author":"Dockrell","year":"2021","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127486_bb0015","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/imr.12965","article-title":"BCG-induced protection against Mycobacterium tuberculosis infection: evidence, mechanisms, and implications for next-generation vaccines","volume":"301","author":"Foster","year":"2021","journal-title":"Immunol Rev"},{"issue":"7","key":"10.1016\/j.vaccine.2025.127486_bb0020","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1128\/CVI.00162-15","article-title":"Mycobacterium bovis BCG vaccination induces divergent proinflammatory or regulatory T cell responses in adults","volume":"22","author":"Boer","year":"2015","journal-title":"Clin Vaccine Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2025.127486_bb0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0094192","article-title":"CD8+ regulatory T cells, and not CD4+ T cells, dominate suppressive phenotype and function after in vitro live Mycobacterium bovis-BCG activation of human cells","volume":"9","author":"Boer","year":"2014","journal-title":"PloS One"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127486_bb0030","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0022-5347(17)58737-6","article-title":"Intracavitary Bacillus Calmette-Guerin in the treatment of superficial bladder tumors","volume":"116","author":"Morales","year":"1976","journal-title":"J Urol"},{"issue":"4","key":"10.1016\/j.vaccine.2025.127486_bb0035","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1097\/00000658-197410000-00029","article-title":"BCG immunotherapy of malignant melanoma: summary of a seven-year experience","volume":"180","author":"Morton","year":"1974","journal-title":"Ann Surg"},{"issue":"8","key":"10.1016\/j.vaccine.2025.127486_bb0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0041756","article-title":"Proof-of-concept, randomized, controlled clinical trial of Bacillus-Calmette-Guerin for treatment of long-term type 1 diabetes","volume":"7","author":"Faustman","year":"2012","journal-title":"PloS One"},{"issue":"7","key":"10.1016\/j.vaccine.2025.127486_bb0045","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1212\/WNL.53.7.1588","article-title":"Use of Bacille Calmette-Gu\u00e8rin (BCG) in multiple sclerosis","volume":"53","author":"Ristori","year":"1999","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.vaccine.2025.127486_bb0050","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/j.vaccine.2004.09.006","article-title":"Acute lower respiratory tract infections and respiratory syncytial virus in infants in Guinea-Bissau: a beneficial effect of BCG vaccination for girls community based case-control study","volume":"23","author":"Stensballe","year":"2005","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2025.127486_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110502","article-title":"BCG vaccination provides protection against IAV but not SARS-CoV-2","volume":"38","author":"Kaufmann","year":"2022","journal-title":"Cell Rep"},{"issue":"5","key":"10.1016\/j.vaccine.2025.127486_bb0060","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.chom.2011.04.006","article-title":"Trained immunity: a memory for innate host defense","volume":"9","author":"Netea","year":"2011","journal-title":"Cell Host Microbe"},{"issue":"43","key":"10.1016\/j.vaccine.2025.127486_bb0065","doi-asserted-by":"crossref","first-page":"17537","DOI":"10.1073\/pnas.1202870109","article-title":"Bacille Calmette-Gu\u00e9rin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes","volume":"109","author":"Kleinnijenhuis","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"10.1016\/j.vaccine.2025.127486_bb0070","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/s41577-020-0337-y","article-title":"BCG-induced trained immunity: can it offer protection against COVID-19?","volume":"20","author":"O\u2019Neill","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2025.127486_bb0075","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/s41577-024-00990-1","article-title":"Integrated organ immunity: a path to a universal vaccine","volume":"24","author":"Pulendran","year":"2024","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2025.127486_bb0080","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41590-023-01700-0","article-title":"BCG vaccination stimulates integrated organ immunity by feedback of the adaptive immune response to imprint prolonged innate antiviral resistance","volume":"25","author":"Lee","year":"2024","journal-title":"Nat Immunol"},{"key":"10.1016\/j.vaccine.2025.127486_bb0085","unstructured":"Freund's Adjuvant, Complete and Incomplete, Sigma Product Information Sheet, Product No. F5881 and F5506. https:\/\/www.sigmaaldrich.com\/deepweb\/assets\/sigmaaldrich\/product\/documents\/335\/648\/f5881pis.pdf."},{"issue":"10","key":"10.1016\/j.vaccine.2025.127486_bb0090","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1111\/j.1349-7006.2009.01271.x","article-title":"Immunotherapy of ovarian cancer with cell wall skeleton of Mycobacterium bovis Bacillus Calmette-Gu\u00e9rin: effect of lymphadenectomy","volume":"100","author":"Hayashi","year":"2009","journal-title":"Cancer Sci"},{"issue":"4","key":"10.1016\/j.vaccine.2025.127486_bb0095","first-page":"218","article-title":"Optimization of cell-wall skeleton derived from Mycobacterium bovis BCG Tokyo 172 (SMP-105) emulsion in delayed-type hypersensitivity and antitumor models","volume":"6","author":"Miyauchi","year":"2012","journal-title":"Drug Discov Ther"},{"issue":"4","key":"10.1016\/j.vaccine.2025.127486_bb0100","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1002\/1097-0142(197904)43:4<1314::AID-CNCR2820430420>3.0.CO;2-6","article-title":"Adjuvant immunotherapy of lung cancer with BCG cell wall skeleton (BCG-CWS)","volume":"43","author":"Yamamura","year":"1979","journal-title":"Cancer"},{"issue":"33","key":"10.1016\/j.vaccine.2025.127486_bb0105","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000016771","article-title":"Immune adjuvant therapy using Bacillus Calmette-Gu\u00e9rin cell wall skeleton (BCG-CWS) in advanced malignancies: a phase 1 study of safety and immunogenicity assessments","volume":"98","author":"Nishida","year":"2019","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"10.1016\/j.vaccine.2025.127486_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2020.e04064","article-title":"Adjuvant activity of mycobacteria-derived mycolic acids","volume":"6","author":"Kubota","year":"2020","journal-title":"Heliyon"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127486_bb0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0209196","article-title":"Cationized liposomal keto-mycolic acids isolated from Mycobacterium bovis bacillus Calmette-Gu\u00e9rin induce antitumor immunity in a syngeneic murine bladder cancer model","volume":"14","author":"Yoshino","year":"2019","journal-title":"PloS One"},{"issue":"9","key":"10.1016\/j.vaccine.2025.127486_bb0120","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1007\/s00262-021-02870-2","article-title":"The liposome of trehalose dimycolate extracted from M. bovis BCG induces antitumor immunity via the activation of dendritic cells and CD8+ T cells","volume":"70","author":"Shiga","year":"2021","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.vaccine.2025.127486_bb0125","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.615091","article-title":"Immunological hallmarks for clinical response to BCG in bladder cancer","volume":"11","author":"Lim","year":"2021","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2025.127486_bb0130","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/joim.13037","article-title":"Clinical and molecular insights into BCG immunotherapy for melanoma","volume":"288","author":"Kremenovic","year":"2020","journal-title":"J Intern Med"},{"issue":"12","key":"10.1016\/j.vaccine.2025.127486_bb0135","doi-asserted-by":"crossref","first-page":"3310","DOI":"10.1128\/iai.56.12.3310-3312.1988","article-title":"Induction of nonspecific acquired resistance and delayed-type hypersensitivity, but not specific acquired resistance in mice inoculated with killed mycobacterial vaccines","volume":"56","author":"Orme","year":"1988","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2025.127486_bb0140","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1055\/s-0029-1206810","article-title":"Weitere Mittheilungen uber das Tuberkulin","volume":"17","author":"Koch","year":"1891","journal-title":"Dt Med Wochenschr"},{"key":"10.1016\/j.vaccine.2025.127486_bb0145","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1001\/jama.1909.25420350001001","article-title":"Frequency of tuberculosis in childhood","volume":"52","author":"von Pirquet","year":"1909","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2025.127486_bb0150","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1126\/science.63.1642.619-c","article-title":"The isolation of a crystalline protein with tuberculin activity","volume":"63","author":"Seibert","year":"1926","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2025.127486_bb0155","first-page":"9","article-title":"Tuberculin purified protein derivative. Preparation and analysis of a large quantity for standard","volume":"44","author":"Seibert","year":"1941","journal-title":"Am Rev Tuberc"},{"key":"10.1016\/j.vaccine.2025.127486_bb0160","first-page":"41","article-title":"The immunology and chemistry of tuberculin. II. Chromatography with Sephadex of the nondialyzable tuberculin-active constituents of BCG culture filtrate","volume":"89","author":"Chaparas","year":"1964","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.vaccine.2025.127486_bb0165","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1128\/iai.7.5.777-780.1973","article-title":"Comparison of strains of BCG. I. Antigenic analysis and tuberculin reactivity","volume":"7","author":"Chaparas","year":"1973","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2025.127486_bb0170","first-page":"979","article-title":"Comparison of antigenic fractions obtained by Seibert and Affronti method from protoplasm and culture filtrates of Mycobacterium bovis (BCG)","volume":"101","author":"Larson","year":"1970","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.vaccine.2025.127486_bb0175","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1139\/m75-290","article-title":"Purification and characterization of tuberculin-active components from BCG","volume":"21","author":"Laguerre","year":"1975","journal-title":"Can J Microbiol"},{"key":"10.1016\/j.vaccine.2025.127486_bb0180","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1139\/m77-104","article-title":"Use of sepharose-conjugated BCG antibodies for the purification of tuberculin-active components","volume":"23","author":"Laguerre","year":"1977","journal-title":"Can J Microbiol"},{"issue":"3","key":"10.1016\/j.vaccine.2025.127486_bb0185","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1128\/iai.31.3.1152-1160.1981","article-title":"Specific skin-reactive protein from culture filtrate of Mycobacterium bovis BCG","volume":"31","author":"Nagai","year":"1981","journal-title":"Infect Immun"},{"issue":"9","key":"10.1016\/j.vaccine.2025.127486_bb0190","first-page":"585","article-title":"Antigen proteins specific to mycobacteria","volume":"64","author":"Nagai","year":"1989","journal-title":"Kekkaku"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127486_bb0195","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1128\/iai.59.1.372-382.1991","article-title":"Isolation and partial characterization of major protein antigens in the culture fluid of Mycobacterium tuberculosis","volume":"59","author":"Nagai","year":"1991","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127486_bb0200","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1128\/iai.52.1.293-302.1986","article-title":"Properties of proteins MPB64, MPB70, and MPB80 of Mycobacterium bovis BCG","volume":"52","author":"Harboe","year":"1986","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127486_bb0205","doi-asserted-by":"crossref","first-page":"15","DOI":"10.7883\/yoken1952.49.15","article-title":"Effective isolation of MPB64 from a large volume of culture filtrate of Mycobacterium bovis BCG Tokyo","volume":"49","author":"Haga","year":"1996","journal-title":"Jpn J Med Sci Biol"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127486_bb0210","first-page":"68","article-title":"Isolation of MPB63 in the culture fluid of Mycobacterium bovis BCG Tokyo: genetical and immunological characterization","volume":"78","author":"Kawajiri","year":"2003","journal-title":"Kekkaku"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127486_bb0215","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1365-3083.1995.tb03624.x","article-title":"Homology between the MPB70 and MPB83 proteins of Mycobacterium bovis BCG","volume":"42","author":"Harboe","year":"1995","journal-title":"Scand J Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2025.127486_bb0220","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1128\/cdli.3.5.541-546.1996","article-title":"Purification of Mycobacterium bovis BCG Tokyo antigens by chromatofocusing, lectin-affinity chromatography, and hydrophobic interaction chromatography","volume":"3","author":"Sugden","year":"1996","journal-title":"Clin Diagn Lab Immunol"},{"issue":"12","key":"10.1016\/j.vaccine.2025.127486_bb0225","doi-asserted-by":"crossref","first-page":"4946","DOI":"10.1128\/iai.63.12.4946-4948.1995","article-title":"Identification and functional characterization of thioredoxin of Mycobacterium tuberculosis","volume":"63","author":"Wieles","year":"1995","journal-title":"Infect Immun"},{"issue":"4","key":"10.1016\/j.vaccine.2025.127486_bb0230","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1128\/mr.56.4.648-661.1992","article-title":"The antigen 85 complex: a major secretion product of Mycobacterium tuberculosis","volume":"56","author":"Wiker","year":"1992","journal-title":"Microbiol Rev"},{"issue":"9","key":"10.1016\/j.vaccine.2025.127486_bb0235","doi-asserted-by":"crossref","first-page":"3847","DOI":"10.1128\/jb.170.9.3847-3854.1988","article-title":"Cloning and expression of the Mycobacterium bovis BCG gene for extracellular alpha antigen","volume":"170","author":"Matsuo","year":"1988","journal-title":"J Bacteriol"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127486_bb0240","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1128\/iai.57.1.283-288.1989","article-title":"Cloning and characterization of the gene for immunogenic protein MPB64 of Mycobacterium bovis BCG","volume":"57","author":"Yamaguchi","year":"1989","journal-title":"Infect Immun"},{"issue":"10","key":"10.1016\/j.vaccine.2025.127486_bb0245","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1128\/iai.57.10.3123-3130.1989","article-title":"Cloning, sequence determination, and expression of a 32-kilodalton-protein gene of Mycobacterium tuberculosis","volume":"57","author":"Borremans","year":"1989","journal-title":"Infect Immun"},{"issue":"10","key":"10.1016\/j.vaccine.2025.127486_bb0250","doi-asserted-by":"crossref","first-page":"4003","DOI":"10.1128\/iai.63.10.4003-4010.1995","article-title":"Cloning, sequencing, and expression of the apa gene coding for the Mycobacterium tuberculosis 45\/47-kilodalton secreted antigen complex","volume":"63","author":"Laqueyrerie","year":"1995","journal-title":"Infect Immun"},{"issue":"6","key":"10.1016\/j.vaccine.2025.127486_bb0255","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1128\/iai.62.6.2536-2544.1994","article-title":"Effective vaccination of mice against Mycobacterium tuberculosis infection with a soluble mixture of secreted mycobacterial proteins","volume":"62","author":"Andersen","year":"1994","journal-title":"Infect Immun"},{"issue":"5","key":"10.1016\/j.vaccine.2025.127486_bb0260","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1073\/pnas.92.5.1530","article-title":"Protective immunity against tuberculosis induced by vaccination with major extracellular proteins of Mycobacterium tuberculosis","volume":"92","author":"Horwitz","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"25","key":"10.1016\/j.vaccine.2025.127486_bb0265","doi-asserted-by":"crossref","first-page":"13853","DOI":"10.1073\/pnas.250480397","article-title":"Recombinant Bacillus Calmette-Guerin (BCG) vaccines expressing the Mycobacterium tuberculosis 30-kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model","volume":"97","author":"Horwitz","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127486_bb0270","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/s41541-021-00386-5","article-title":"Long-term protective immunity induced by an adjuvant-containing live-attenuated AIDS virus","volume":"6","author":"Okamura","year":"2021","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.vaccine.2025.127486_bb0275","doi-asserted-by":"crossref","first-page":"4310","DOI":"10.1038\/s41598-022-08228-7","article-title":"Monitoring IgG against Mycobacterium tuberculosis proteins in an Asian elephant cured of tuberculosis that developed from long-term latency","volume":"12","author":"Ishikawa","year":"2002","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2025.127486_bb0280","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1126\/science.276.5317.1420","article-title":"Role of the major antigen of Mycobacterium tuberculosis in cell wall biogenesis","volume":"276","author":"Belisle","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2025.127486_bb0285","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.4049\/jimmunol.177.3.1780","article-title":"Phenotypical and functional analysis of memory and effector human CD8 T cells specific for mycobacterial antigens","volume":"177","author":"Caccamo","year":"2006","journal-title":"J Immunol"},{"issue":"9","key":"10.1016\/j.vaccine.2025.127486_bb0290","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1002\/eji.201343454","article-title":"Heterologous vaccination against human tuberculosis modulates antigen-specific CD4+ T-cell function","volume":"43","author":"Dintwe","year":"2013","journal-title":"Eur J Immunol"},{"issue":"38","key":"10.1016\/j.vaccine.2025.127486_bb0295","doi-asserted-by":"crossref","first-page":"5616","DOI":"10.1016\/j.vaccine.2012.06.084","article-title":"Effect of vaccine dose on the safety and immunogenicity of a candidate TB vaccine, MVA85A, in BCG vaccinated UK adults","volume":"30","author":"Pathan","year":"2012","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2025.127486_bb0300","article-title":"Alternate aerosol and systemic immunisation with a recombinant viral vector for tuberculosis, MVA85A: a phase I randomised controlled trial","volume":"16","author":"Thomas","year":"2019","journal-title":"PLoS Med"},{"key":"10.1016\/j.vaccine.2025.127486_bb0305","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.micpath.2017.08.040","article-title":"Antigen 85 complex as a powerful Mycobacterium tuberculosis immunogene: biology, immune-pathogenicity, applications in diagnosis, and vaccine design","volume":"112","author":"Babaki","year":"2017","journal-title":"Microb Pathog"},{"issue":"7","key":"10.1016\/j.vaccine.2025.127486_bb0310","article-title":"MPT64 protein from Mycobacterium tuberculosis inhibits apoptosis of macrophages through NF-kB-miRNA21-Bcl-2 pathway","volume":"9","author":"Wang","year":"2014","journal-title":"PloS One"},{"issue":"11","key":"10.1016\/j.vaccine.2025.127486_bb0315","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s00018-022-04596-5","article-title":"Mycobacterium tuberculosis exploits MPT64 to generate myeloid-derived suppressor cells to evade the immune system","volume":"79","author":"Singh","year":"2022","journal-title":"Cell Mol Life Sci"},{"issue":"12","key":"10.1016\/j.vaccine.2025.127486_bb0320","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1038\/modpathol.3800697","article-title":"Immunohistochemistry using a Mycobacterium tuberculosis complex specific antibody for improved diagnosis of tuberculous lymphadenitis","volume":"19","author":"Mustafa","year":"2006","journal-title":"Mod Pathol"},{"key":"10.1016\/j.vaccine.2025.127486_bb0325","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1746-1596-2-36","article-title":"Immunohistochemical diagnosis of abdominal and lymph node tuberculosis by detecting Mycobacterium tuberculosis complex specific antigen MPT64","volume":"2","author":"Purohit","year":"2007","journal-title":"Diagn Pathol"},{"issue":"6","key":"10.1016\/j.vaccine.2025.127486_bb0330","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1097\/PAI.0b013e31816c3f79","article-title":"Rapid and specific diagnosis of tuberculous pleuritis with immunohistochemistry by detecting Mycobacterium tuberculosis complex specific antigen MPT64 in patients from a HIV endemic area","volume":"16","author":"Baba","year":"2008","journal-title":"Appl Immunohistochem Mol Morphol"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127486_bb0335","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1186\/s12879-014-0585-1","article-title":"Immunocytochemical detection of Mycobacterium tuberculosis complex specific antigen, MPT64, improves diagnosis of tuberculous lymphadenitis and tuberculous pleuritis","volume":"14","author":"Tadele","year":"2014","journal-title":"BMC Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2025.127486_bb0340","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1097\/PAI.0000000000000300","article-title":"Rapid and specific diagnosis of extrapulmonary tuberculosis by immunostaining of tissues and aspirates with anti-MPT64","volume":"25","author":"Purohit","year":"2017","journal-title":"Appl Immunohistochem Mol Morphol"},{"issue":"7","key":"10.1016\/j.vaccine.2025.127486_bb0345","doi-asserted-by":"crossref","first-page":"3454","DOI":"10.1128\/IAI.66.7.3454-3456.1998","article-title":"Delayed-type hypersensitivity responses to ESAT-6 and MPT64 from Mycobacterium tuberculosis in the Guinea pig","volume":"66","author":"Elhay","year":"1998","journal-title":"Infect Immun"},{"issue":"5","key":"10.1016\/j.vaccine.2025.127486_bb0350","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1128\/jb.178.5.1274-1282.1996","article-title":"Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis","volume":"178","author":"Mahairas","year":"1996","journal-title":"J Bacteriol"},{"key":"10.1016\/j.vaccine.2025.127486_bb0355","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.103007","article-title":"A novel, rapid (within hours) culture-free diagnostic method for detecting live Mycobacterium tuberculosis with high sensitivity","volume":"60","author":"Wang","year":"2020","journal-title":"EBioMedicine"},{"key":"10.1016\/j.vaccine.2025.127486_bb0360","doi-asserted-by":"crossref","first-page":"240","DOI":"10.2144\/btn-2019-0020","article-title":"Immunochromatographic detection of MPB64 secreted from active BCG by heating: toward same-day diagnosis of tuberculosis","volume":"66","author":"Nakaishi","year":"2019","journal-title":"Biotechniques"},{"key":"10.1016\/j.vaccine.2025.127486_bb0365","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ijid.2020.04.059","article-title":"Ultrasensitive enzyme-linked immunosorbent assay for the detection of MPT64 secretory antigen to evaluate Mycobacterium tuberculosis viability in sputum","volume":"96","author":"Sakashita","year":"2020","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.vaccine.2025.127486_bb0370","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1128\/iai.65.1.16-23.1997","article-title":"Molecular cloning, purification, and serological characterization of MPT63, a novel antigen secreted by Mycobacterium tuberculosis","volume":"65","author":"Manca","year":"1997","journal-title":"Infect Immun"},{"issue":"7\u20138","key":"10.1016\/j.vaccine.2025.127486_bb0375","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1007\/s00431-003-1199-6","article-title":"The potential of recombinant antigens ESAT-6, MPT63 and mig for specific discrimination of Mycobacterium tuberculosis and M. avium infection","volume":"162","author":"Rolinck-Werninghaus","year":"2003","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.vaccine.2025.127486_bb0380","doi-asserted-by":"crossref","first-page":"5344","DOI":"10.1128\/IAI.66.11.5344-5349.1998","article-title":"Diversity of antigen recognition by serum antibodies in experimental bovine tuberculosis","volume":"66","author":"Lyashchenko","year":"1998","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2025.127486_bb0385","doi-asserted-by":"crossref","first-page":"3936","DOI":"10.1128\/IAI.66.8.3936-3940.1998","article-title":"Heterogeneous antibody responses in tuberculosis","volume":"66","author":"Lyashchenko","year":"1998","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2025.127486_bb0390","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1365-3083.2008.02221.x","article-title":"Th1 cell reactivity and HLA-DR binding prediction for promiscuous recognition of MPT63 (Rv1926c), a major secreted protein of Mycobacterium tuberculosis","volume":"69","author":"Mustafa","year":"2009","journal-title":"Scand J Immunol"},{"issue":"7","key":"10.1016\/j.vaccine.2025.127486_bb0395","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1021\/acschembio.9b00327","article-title":"Conformational switch driven membrane pore formation by Mycobacterium secretory protein MPT63 induces macrophage cell death","volume":"14","author":"Sannigrahi","year":"2019","journal-title":"ACS Chem Biol"},{"key":"10.1016\/j.vaccine.2025.127486_bb0400","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202402953","article-title":"Conformational switch of a peptide provides a novel strategy to design peptide loaded porous organic polymer for pyroptosis pathway mediated cancer therapy","author":"Mishra","year":"2024","journal-title":"Small"},{"key":"10.1016\/j.vaccine.2025.127486_bb0405","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1128\/jb.178.9.2498-2506.1996","article-title":"Definition of the full extent of glycosylation of the 45-kilodalton glycoprotein of Mycobacterium tuberculosis","volume":"178","author":"Dobos","year":"1996","journal-title":"J Bacteriol"},{"key":"10.1016\/j.vaccine.2025.127486_bb0410","first-page":"378","article-title":"Identification, isolation and partial characterization of Mycobacterium tuberculosis glycoprotein antigens","volume":"77","author":"Espitia","year":"1989","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.vaccine.2025.127486_bb0415","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1128\/IAI.71.4.1929-1937.2003","article-title":"The Apa protein of Mycobacterium tuberculosis stimulates gamma interferon-secreting CD4+ and CD8+ T cells from purified protein derivative-positive individuals and affords protection in a guinea pig model","volume":"71","author":"Kumar","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2025.127486_bb0420","doi-asserted-by":"crossref","first-page":"5567","DOI":"10.1128\/IAI.67.11.5567-5572.1999","article-title":"Deglycosylation of the 45\/47-kiloDalton antigen complex of Mycobacterium tuberculosis decreases its capacity to elicit in vivo or in vitro cellular immune responses","volume":"67","author":"Romain","year":"1999","journal-title":"Infect Immun"},{"issue":"10","key":"10.1016\/j.vaccine.2025.127486_bb0425","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003705","article-title":"O-mannosylation of the Mycobacterium tuberculosis adhesin Apa is crucial for T cell antigenicity during infection but is expendable for protection","volume":"9","author":"Nandakumar","year":"2013","journal-title":"PLoS Pathog"},{"issue":"8","key":"10.1016\/j.vaccine.2025.127486_bb0430","doi-asserted-by":"crossref","first-page":"5133","DOI":"10.1074\/jbc.M610183200","article-title":"The Mycobacterium tuberculosis cell-surface glycoprotein apa as a potential adhesin to colonize target cells via the innate immune system pulmonary C-type lectin surfactant protein A","volume":"282","author":"Ragas","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2025.127486_bb0435","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/(SICI)1097-0215(20000401)86:1<83::AID-IJC13>3.0.CO;2-R","article-title":"Role of a bacillus Calmette-Guerin fibronectin attachment protein in BCG-induced antitumor activity","volume":"86","author":"Zhao","year":"2000","journal-title":"Int J Cancer"},{"key":"10.1016\/j.vaccine.2025.127486_bb0440","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0022718","article-title":"Cellular immune responses to nine Mycobacterium tuberculosis vaccine candidates following intranasal vaccination","volume":"6","author":"Sable","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.vaccine.2025.127486_bb0445","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1016\/S0264-410X(01)00012-3","article-title":"Mixed immune response induced in rodents by two naked DNA genes coding for mycobacterial glycosylated proteins","volume":"19","author":"Garapin","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.127486_bb0450","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1002\/eji.201344100","article-title":"TLR2 engagement on CD4(+) T cells enhances effector functions and protective responses to Mycobacterium tuberculosis","volume":"44","author":"Reba","year":"2014","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2025.127486_bb0455","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1271228","article-title":"Culture filtrate proteins from BCG act as adjuvants for cytotoxic T lymphocyte induction","volume":"14","author":"Mizuno","year":"2023","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127486_bb0460","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1128\/iai.65.2.676-684.1997","article-title":"Induction of cytotoxic T-cell responses against culture filtrate antigens in Mycobacterium bovis bacillus Calmette-Gu\u00e9rin-infected mice","volume":"65","author":"Denis","year":"1997","journal-title":"Infect Immun"},{"issue":"9","key":"10.1016\/j.vaccine.2025.127486_bb0465","doi-asserted-by":"crossref","first-page":"5809","DOI":"10.1128\/IAI.73.9.5809-5816.2005","article-title":"Tracking antigen-specific CD8 T lymphocytes in the lungs of mice vaccinated with the Mtb72F polyprotein","volume":"73","author":"Irwin","year":"2005","journal-title":"Infect Immun"},{"issue":"5","key":"10.1016\/j.vaccine.2025.127486_bb0470","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0034991","article-title":"The secreted lipoprotein, MPT83, of Mycobacterium tuberculosis is recognized during human tuberculosis and stimulates protective immunity in mice","volume":"7","author":"Kao","year":"2012","journal-title":"PloS One"},{"issue":"12","key":"10.1016\/j.vaccine.2025.127486_bb0475","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/s41577-022-00707-2","article-title":"A guide to antigen processing and presentation","volume":"22","author":"Pishesha","year":"2022","journal-title":"Nat Rev Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25007832?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25007832?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T03:25:29Z","timestamp":1766546729000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X25007832"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":95,"alternative-id":["S0264410X25007832"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127486","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Culture filtrate proteins from Bacillus Calmette\u2013Gu\u00e9rin","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127486","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"127486"}}